-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Friday's Intraday Session
Share
Listen to the news

Gainers

  • Gelteq (NASDAQ:GELS) shares rose 77.1% to $1.7 during Friday's regular session. The company's market cap stands at $9.6 million.
  • SINTX Technologies (NASDAQ:SINT) stock rose 32.64% to $5.81. The market value of their outstanding shares is at $12.0 million.
  • iSpecimen (NASDAQ:ISPC) shares increased by 32.1% to $0.88. The market value of their outstanding shares is at $5.5 million.
  • Olema Pharmaceuticals (NASDAQ:OLMA) stock rose 27.79% to $8.12. The market value of their outstanding shares is at $435.8 million.
  • Equillium (NASDAQ:EQ) stock rose 23.71% to $2.17. The company's market cap stands at $62.5 million.
  • MSP Recovery (NASDAQ:MSPR) shares rose 21.87% to $2.73. The company's market cap stands at $2.0 million.

Losers

  • NovaBay Pharmaceuticals (AMEX:NBY) shares fell 23.0% to $3.25 during Friday's regular session. The market value of their outstanding shares is at $24.5 million.
  • Purple Biotech (NASDAQ:PPBT) stock declined by 21.8% to $0.61. The company's market cap stands at $2.0 million.
  • Mobile-health Network (NASDAQ:MNDR) stock declined by 19.86% to $0.77. The market value of their outstanding shares is at $5.4 million.
  • Bone Biologics (NASDAQ:BBLG) stock declined by 17.06% to $2.36. The company's market cap stands at $4.5 million.
  • Pro-Dex (NASDAQ:PDEX) stock decreased by 12.49% to $40.03. The market value of their outstanding shares is at $149.1 million. As per the press release, Q4 earnings came out yesterday.
  • PainReform (NASDAQ:PRFX) stock fell 12.01% to $1.43. The company's market cap stands at $3.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending